The potential for ACEi and/or ARB use to increase ACE2 expression raised concerns about the possible exacerbation of viral load and the development of more severe forms of COVID-19 [13,32,33], as higher ACE2 levels could theoretically enhance viral load and worsen disease outcomes. Here, ACE2 is linked to COVID-19.